Page last updated: 2024-08-17

aspartic acid and Cognitive Decline

aspartic acid has been researched along with Cognitive Decline in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	37 (69.81)	24.3611
2020's	16 (30.19)	2.80

Authors

Authors	Studies
Cordato, DJ; Shad, KF; Soubra, W	1
Izuo, N; Kitazawa, A; Miyanishi, H; Muramatsu, SI; Nitta, A	1
Liu, Y; Niu, X; Zhang, J; Zhang, Y	1
Dacorro, L; Fingerhut, H; Gozdas, E; Gu, M; Hinkley, L; Hosseini, SMH; Hurd, R; Sacchet, MD	1
Chen, YY; Chou, YH; Liu, MN; Yang, BH; Yang, KC	1
Chen, G; Chen, P; Duan, M; Huang, X; Jia, Y; Lai, S; Lu, X; Song, K; Wang, Y; Ye, K; Zhang, Y; Zhong, S	1
Česnaitienė, VJ; Drozdova-Statkevičienė, M; Dudonienė, V; Gleiznienė, R; Himmelreich, U; Katkutė, G; Kušleikienė, S; Levin, O; Masiulis, N; Pääsuke, M; Sheoran, S; Valatkevičienė, K; Vints, WAJ; Ziv, G	1
Chitty, K; Haber, PS; Lagopoulos, J; Logge, W; Morley, KC; Moustafa, AA	1
Hong, Q; Li, S; Lian, X; Yin, C; Zhao, W	1
Atiya, S; Bartha, R; Borrie, MJ; Brymer, C; Fogarty, J; Montero-Odasso, M; Pasternak, SH; Wong, D	1
Chaudhary, S; Goyal, V; Jagannathan, NR; Kalaivani, M; Kaloiya, GS; Kumaran, SS; Mehta, N; Sagar, R; Srivastava, AK	1
Balcioglu, YH; Sen, M; Yesilkaya, UH	1
Alirezaei, Z; Amouheidari, A; Davanian, F; Hassanpour, M; Iraji, S; Nazem-Zadeh, MR; Shokrani, P	1
Chen, X; Ding, Y; Gao, M; He, N; Lin, H; Shen, W; Xu, X; Zhu, B	1
Briemberg, H; Eurich, DT; Frayne, R; Genge, AL; Graham, SJ; Hanstock, C; Ishaque, A; Kalra, S; Korngut, L; Luk, C; Seres, P; Srivastava, O; Ta, D; Zinman, L	1
Chen, W; Gong, ZK; Sheng, C; Wang, M; Wang, SY; Wang, XX	1
Chang, CC; Chen, CS; Hsu, JS; Jaw, TS; Lai, JJ; Li, CW; Shih, CM; Yeh, YC	1
Moriya, M; Nojo, T; Waragai, M	1
Bagnoli, S; Berti, V; Bessi, V; Braccia, A; Del Mastio, M; Matà, S; Nacmias, B; Piaceri, I; Pignone, AM; Polito, C; Pupi, A; Sorbi, S; Tedde, A	1
Denney, TS; Gawne, TJ; Lahti, AC; Reid, MA; Salibi, N; White, DM	1
Peleg-Raibstein, D; Wolfrum, C	1
Aslan, S; Chen, JR; Choi, C; Khan, DA; Kroll, JL; Patel, SV; Pinkham, AE; Ritz, T; Sherwood Brown, E; Steele, AM	1
Alakkas, A; Clifford, DB; Collier, A; Ellis, RJ; Fennema-Notestine, C; Gelman, B; Gianella, S; Grant, I; Heaton, RK; Kallianpur, A; Letendre, S; Marcotte, T; Marra, C; McCutchan, JA; Morgello, S; Sacktor, N; Simpson, D; Umlauf, A; Watson, CW	1
Chang, TY; Hsiao, IT; Huang, CC; Huang, CY; Huang, KL; Lin, KJ; Liu, CH; Weng, YC; Yen, TC	1
Guo, X; Han, D; He, J; Li, Y; Li, Z; Liu, H; Liu, T; Manyande, A; Tian, X; Wang, J; Xiang, H; Xu, F; Yang, N	1
Cai, ZL; Liu, Y; Wu, F; Xue, S; Zhou, X	1
Kantarci, K	1
Andrade-Valença, LP; Menezes, TL; Valença, MM	1
Aleman, A; Martens, S; Tumati, S	1
Augusciak-Duma, AM; Banasik, TJ; Bujak, MA; Opala, G; Siuda, JS; Targosz-Gajniak, MG; Wicher, MM	1
Alvarez-Linera, J; Frank, A; García-Álvarez, R; Hernández-Tamames, JA; Loureiro, JP; Mato Abad, V; Quirós, A	1
Sukying, C; Suriyajakryuththana, W; Teepprasarn, N; Tuntiyatorn, L	1
Amann, M; Babb, JS; Gass, A; Glodzik, L; Gokhale, A; Gonen, O; Hirsch, JG; Monsch, AU; Rusinek, H; Sollberger, M	1
Akiguchi, I; Shiino, A; Watanabe, T	1
Almuqbel, M; Anderson, TJ; Dalrymple-Alford, JC; Keenan, RJ; Livingston, L; MacAskill, MR; Melzer, TR; Myall, DJ; Pitcher, TL; Wood, KL	1
Anderson, PJ; Bainbridge, A; Burnett, AC; Cheong, JL; Doyle, LW; Lee, KJ; Roberts, G; Robertson, NJ; Thompson, DK; Wood, SJ	1
Meng, N; Shi, S; Su, Y	1
D'Aniello, A; de Bartolomeis, A; de Novellis, V; Guida, F; Iannotta, M; Luongo, L; Maione, S; Marabese, I; Marmo, F; Palazzo, E; Romano, R; Rossi, F; Stella, L; Usiello, A	1
Chen, W; Chen, X; Guo, Z; Hou, H; Liu, X; Shen, Y; Wei, F	1
Hwang, J; Jeon, S; Kang, I; Kim, B; Kim, GH; Kim, JE; Kim, JY; Lyoo, IK; Ma, J; Renshaw, PF; Yoon, S; Yurgelun-Todd, DA	1
Bulik, M; Burkon, P; Dobiaskova, M; Hynkova, L; Jancalek, R; Kazda, T; Laack, NN; Pospisil, P; Slampa, P	1
Choudhary, AK; Lee, YY	1
Daly, EM; Foy, CM; Glover, A; Lovestone, S; Murphy, DG; O'Gorman, R; Simmons, A	1
Chen, K; Ding, B; Fang, Y; Li, X; Ling, H; Wang, T; Xiao, S	1
Lyutvinskiy, Y; Soininen, H; Yang, H; Zubarev, RA	1
Arlt, S; Block, W; Ende, G; Frölich, L; Gür, O; Hammen, T; Jessen, F; Kornhuber, J; Kucinski, T; Lewczuk, P; Maier, W; Peters, O; Popp, J; Träber, F; Wiltfang, J	1
Aguilar, K; Fayed, N; Modrego, PJ; Rojas-Salinas, G	1
Barcikowska, M; Ćwikła, JB; Gabryelewicz, T; Walecki, J	1
Andreiuolo, PA; Bottino, CM; de Oliveira-Souza, R; Moll, J; Silveira de Souza, A; Tovar-Moll, F	1
Fayed, N; Modrego, PJ	1
Choi, JY; Hong, YH; Kim, HS; Lim, TS; Moon, SY	1
Delfino, M; García-Sánchez, C; Gironell, A; Gómez-Ansón, B; Kulisevsky, J; Llebaria, G; Pagonabarraga, J; Pascual-Sedano, B; Rotger, R; Ruscalleda, J	1
Gan, R; Huang, B; Huang, Z; Nie, K; Wang, L; Zhang, Y; Zhao, J	1

Reviews

3 review(s) available for aspartic acid and Cognitive Decline

Article	Year
Proton MRS in mild cognitive impairment. Journal of magnetic resonance imaging : JMRI, 2013, Volume: 37, Issue:4 Topics: Alzheimer Disease; Animals; Aspartic Acid; Biomarkers; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; Diagnosis, Differential; Disease Models, Animal; Disease Progression; Energy Metabolism; Humans; Inositol; Magnetic Resonance Spectroscopy; Mice; Translational Research, Biomedical	2013
Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis. Neuroscience and biobehavioral reviews, 2013, Volume: 37, Issue:10 Pt 2 Topics: Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Humans; Inositol; Magnetic Resonance Spectroscopy	2013
Neurophysiological symptoms and aspartame: What is the connection? Nutritional neuroscience, 2018, Volume: 21, Issue:5 Topics: Affect; Animals; Aspartame; Aspartic Acid; Brain; Cognitive Dysfunction; Disease Models, Animal; Dopamine; Free Radicals; Humans; Hydrocortisone; Migraine Disorders; Nervous System Diseases; Neurotransmitter Agents; Non-Nutritive Sweeteners; Norepinephrine; Oxidative Stress; Phenylalanine; Seizures; Serotonin; Sleep Initiation and Maintenance Disorders	2018

Other Studies

50 other study(ies) available for aspartic acid and Cognitive Decline

Article	Year
The Auditory Afferent Pathway as a Clinical Marker of Alzheimer's Disease. Journal of Alzheimer's disease : JAD, 2022, Volume: 85, Issue:1 Topics: Acoustic Stimulation; Afferent Pathways; Aged; Alzheimer Disease; Aspartic Acid; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Creatine; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mental Status and Dementia Tests; Middle Aged; Temporal Lobe	2022
N-Acetyl Transferase, Shati/Nat8l, in the Dorsal Hippocampus Suppresses Aging-induced Impairment of Cognitive Function in Mice. Neurochemical research, 2022, Volume: 47, Issue:9 Topics: Acetyltransferases; Aging; Animals; Aspartic Acid; Cognition; Cognitive Dysfunction; Hippocampus; Mice; Mice, Inbred C57BL	2022
Naringenin Attenuates Cognitive Impairment in a Rat Model of Vascular Dementia by Inhibiting Hippocampal Oxidative Stress and Inflammatory Response and Promoting N-Methyl-D-Aspartate Receptor Signaling Pathway. Neurochemical research, 2022, Volume: 47, Issue:11 Topics: Animals; Anti-Inflammatory Agents; Aspartic Acid; Cognitive Dysfunction; Dementia, Vascular; Disease Models, Animal; Disks Large Homolog 4 Protein; Flavanones; Glutathione Peroxidase; Hippocampus; Interleukin-10; Interleukin-4; Interleukin-6; Malondialdehyde; Maze Learning; Oxidative Stress; Rats; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Superoxide Dismutase; Synaptophysin; Tumor Necrosis Factor-alpha	2022
NeuroImage. Clinical, 2022, Volume: 36 Topics: Aged; Alzheimer Disease; Aspartic Acid; Cognition; Cognitive Dysfunction; Creatine; Glutamic Acid; Humans; Inositol; Proton Magnetic Resonance Spectroscopy	2022
Interactions between dopamine transporter and N-methyl-d-aspartate receptor-related amino acids on cognitive impairments in schizophrenia. Schizophrenia research, 2022, Volume: 248 Topics: Amino Acids; Arginine; Aspartic Acid; Cognitive Dysfunction; Corpus Striatum; Cysteine; Dopamine; Dopamine Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Glutamates; Humans; Methionine; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Tropanes	2022
Cognitive dysfunction and neurometabolic alternations in major depressive disorder with gastrointestinal symptoms. Journal of affective disorders, 2023, 02-01, Volume: 322 Topics: Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Depressive Disorder, Major; Humans; Proton Magnetic Resonance Spectroscopy	2023
Neurometabolic correlates of posturography in normal aging and older adults with mild cognitive impairment: Evidence from a NeuroImage. Clinical, 2023, Volume: 37 Topics: Aged; Aging; Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Glutamine; Humans; Inositol; Proton Magnetic Resonance Spectroscopy; Receptors, Antigen, T-Cell	2023
Brain N-Acetyl Aspartate and associations with cognitive impairment in alcohol dependent patients. Journal of clinical and experimental neuropsychology, 2020, Volume: 42, Issue:2 Topics: Adult; Aged; Alcoholism; Aspartic Acid; Brain Chemistry; Cognitive Dysfunction; Female; Humans; Magnetic Resonance Spectroscopy; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Parietal Lobe; Risk-Taking; Trail Making Test	2020
Application of Hydrogen Proton Magnetic Resonance Technology Combined with Brain Neurometabolite Analysis in the Treatment of Cognitive Impairment Caused by Type 2 Diabetes Mellitus. World neurosurgery, 2020, Volume: 138 Topics: Adult; Aged; Aspartic Acid; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Female; Humans; Hydrogen; Male; Middle Aged; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Protons; Treatment Outcome	2020
Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study. Journal of Alzheimer's disease : JAD, 2020, Volume: 73, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Glutamic Acid; Gyrus Cinguli; Hippocampus; Humans; Limbic System; Magnetic Resonance Spectroscopy; Male; Memory, Episodic; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Pilot Projects; White Matter	2020
Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:3 Topics: Aspartic Acid; Brain; Cognitive Dysfunction; Creatine; Frontal Lobe; Gray Matter; Humans; Magnetic Resonance Imaging; Parkinson Disease	2021
COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2021, Volume: 87 Topics: Adult; Aspartic Acid; Cognitive Dysfunction; COVID-19; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Prefrontal Cortex; Signal Transduction	2021
Early Detection of Radiation-Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low-Grade Glioma. BioMed research international, 2021, Volume: 2021 Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Cognitive Dysfunction; Creatine; Early Diagnosis; Female; Glioma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Metabolome; Middle Aged; Neuropsychological Tests; Radiation Injuries; Young Adult	2021
Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection. EBioMedicine, 2021, Volume: 71 Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Atherosclerosis; Cognitive Dysfunction; Female; Glutamic Acid; Glutamine; Glycerophospholipids; HIV Infections; Humans; Liver Cirrhosis; Male; Metabolome; Middle Aged; Plasmalogens; Renal Insufficiency	2021
Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study. Neurology, 2021, 08-24, Volume: 97, Issue:8 Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cognitive Dysfunction; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Prefrontal Cortex; Severity of Illness Index	2021
Study on the clinical application of the MRS in the cognitive assessment after stroke. European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:10 Topics: Aspartic Acid; Cognition; Cognition Disorders; Cognitive Dysfunction; Creatine; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Stroke	2017
Comparison of LCModel and SAGE in Analysis of Brain Metabolite Concentrations-A study of Patients with Mild Cognitive Impairment. Acta neurologica Taiwanica, 2017, Mar-15, Volume: 26, Issue:1 Topics: Aspartic Acid; Brain; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Humans; Magnetic Resonance Spectroscopy	2017
Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study. Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Disease Progression; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Inositol; Lewy Body Disease; Male; Mental Status and Dementia Tests; Parkinson Disease; Prodromal Symptoms; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Risk Factors	2017
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline. Journal of Alzheimer's disease : JAD, 2018, Volume: 61, Issue:1 Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; C9orf72 Protein; Cognitive Dysfunction; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Italy; Male; Mental Status and Dementia Tests; Middle Aged; Mutation; Neuropsychological Tests; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Tyrosine	2018
7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. Schizophrenia bulletin, 2019, 01-01, Volume: 45, Issue:1 Topics: Adult; Aspartic Acid; Cognitive Dysfunction; Female; gamma-Aminobutyric Acid; Glutamic Acid; Gyrus Cinguli; Humans; Male; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Schizophrenia; Young Adult	2019
Maternal overnutrition leads to cognitive and neurochemical abnormalities in C57BL/6 mice. Nutritional neuroscience, 2019, Volume: 22, Issue:10 Topics: Animals; Aspartic Acid; Avoidance Learning; Brain Chemistry; Cognitive Dysfunction; Diet, High-Fat; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Male; Maternal Nutritional Physiological Phenomena; Memory, Short-Term; Mice, Inbred C57BL; Overnutrition; Prepulse Inhibition; Taurine	2019
Hippocampal metabolites in asthma and their implications for cognitive function. NeuroImage. Clinical, 2018, Volume: 19 Topics: Adolescent; Adult; Aspartic Acid; Asthma; Cognition; Cognitive Dysfunction; Creatine; Female; Glutamic Acid; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Young Adult	2018
White matter damage, neuroinflammation, and neuronal integrity in HAND. Journal of neurovirology, 2019, Volume: 25, Issue:1 Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartic Acid; Basal Ganglia; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Choline; Cognitive Dysfunction; Creatine; Female; Gray Matter; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuroimaging; Neuropsychological Tests; Organ Size; Severity of Illness Index; White Matter	2019
Progress of Brain Amyloid Deposition in Familial Alzheimer's Disease with Taiwan D678H APP Mutation. Journal of Alzheimer's disease : JAD, 2018, Volume: 66, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Aspartic Acid; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Family Health; Female; Follow-Up Studies; Histidine; Humans; Male; Middle Aged; Positron-Emission Tomography; Taiwan	2018
Regional Metabolic Patterns of Abnormal Postoperative Behavioral Performance in Aged Mice Assessed by Neuroscience bulletin, 2020, Volume: 36, Issue:1 Topics: Aging; Anesthesia; Animals; Anxiety; Aspartic Acid; Brain; Cerebral Cortex; Cognitive Dysfunction; Female; Glutamic Acid; Hippocampus; Isoflurane; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Motor Activity; Proton Magnetic Resonance Spectroscopy	2020
Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2013, Volume: 20, Issue:4 Topics: Aged; Aged, 80 and over; Aspartic Acid; Biomarkers; Choline; Cognitive Dysfunction; Cognitive Reserve; Creatine; Diagnostic and Statistical Manual of Mental Disorders; Educational Status; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Memory; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Wechsler Scales	2013
Magnetic resonance imaging study cannot individually distinguish individuals with mild cognitive impairment, mild Alzheimer's disease, and normal aging. Arquivos de neuro-psiquiatria, 2013, Volume: 71, Issue:4 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Diagnosis, Differential; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Imaging; Male; Mental Status Schedule; Severity of Illness Index	2013
Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia. Journal of the neurological sciences, 2013, Dec-15, Volume: 335, Issue:1-2 Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Predictive Value of Tests; Protons	2013
The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging. Journal of Alzheimer's disease : JAD, 2014, Volume: 42, Issue:3 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Brain; Cognitive Dysfunction; Female; Functional Laterality; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons	2014
Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2014, Volume: 97, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Cross-Sectional Studies; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged	2014
Global N-acetylaspartate in normal subjects, mild cognitive impairment and Alzheimer's disease patients. Journal of Alzheimer's disease : JAD, 2015, Volume: 43, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Biomarkers; Brain; Cognitive Dysfunction; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Sensitivity and Specificity	2015
[Prediction of conversion from amnestic mild cognitive impairment to Alzheimer's disease using proton magnetic resonance spectroscopy]. Rinsho shinkeigaku = Clinical neurology, 2015, Volume: 55, Issue:10 Topics: Aged; Alzheimer Disease; Amnesia; Aspartic Acid; Cognitive Dysfunction; Disease Progression; Female; Forecasting; Hippocampus; Humans; Male; Proton Magnetic Resonance Spectroscopy	2015
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting. Parkinsonism & related disorders, 2016, Volume: 22 Topics: Aged; Aged, 80 and over; Aspartic Acid; Bayes Theorem; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Superior Sagittal Sinus	2016
Altered posterior cingulate brain metabolites and cognitive dysfunction in preterm adolescents. Pediatric research, 2016, Volume: 79, Issue:5 Topics: Adolescent; Aspartic Acid; Australia; Brain; Cell Membrane; Choline; Cognition; Cognition Disorders; Cognitive Dysfunction; Creatinine; Female; Gyrus Cinguli; Humans; Infant, Premature; Magnetic Resonance Spectroscopy; Male; Neurons; Prospective Studies; Regression Analysis; Treatment Outcome	2016
Proton magnetic resonance spectroscopy as a diagnostic biomarker in mild cognitive impairment following stroke in acute phase. Neuroreport, 2016, 05-25, Volume: 27, Issue:8 Topics: Aged; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Creatine; Female; Hippocampus; Humans; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; Stroke	2016
D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice. Amino acids, 2016, Volume: 48, Issue:7 Topics: Animals; Aspartic Acid; Cognitive Dysfunction; Disks Large Homolog 4 Protein; Homer Scaffolding Proteins; Humans; Hyperalgesia; Male; Mice; Neuralgia; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Sciatic Nerve	2016
(1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease. Comprehensive psychiatry, 2016, Volume: 69 Topics: Aged; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Dominance, Cerebral; Female; Gyrus Cinguli; Humans; Inositol; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy	2016
Metabolic alterations in the anterior cingulate cortex and related cognitive deficits in late adolescent methamphetamine users. Addiction biology, 2018, Volume: 23, Issue:1 Topics: Adolescent; Amphetamine-Related Disorders; Aspartic Acid; Brain; Case-Control Studies; Cognitive Dysfunction; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Proton Magnetic Resonance Spectroscopy; Stroop Test; Young Adult	2018
Post-WBRT cognitive impairment and hippocampal neuronal depletion measured by in vivo metabolic MR spectroscopy: Results of prospective investigational study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2017, Volume: 122, Issue:3 Topics: Aspartic Acid; Biomarkers; Brain Neoplasms; Cognitive Dysfunction; Cranial Irradiation; Female; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Memory; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Prospective Studies; Quality of Life; Surveys and Questionnaires	2017
Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment. Brain topography, 2011, Volume: 24, Issue:3-4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Phosphocreatine; Protons	2011
Using proton magnetic resonance spectroscopy to identify mild cognitive impairment. International psychogeriatrics, 2012, Volume: 24, Issue:1 Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Female; Gyrus Cinguli; Hippocampus; Humans; Inositol; Magnetic Resonance Imaging; Male; Neuroimaging	2012
Alzheimer's disease and mild cognitive impairment are associated with elevated levels of isoaspartyl residues in blood plasma proteins. Journal of Alzheimer's disease : JAD, 2011, Volume: 27, Issue:1 Topics: Alzheimer Disease; Aspartic Acid; Blood Proteins; Cognitive Dysfunction; Female; Humans; Male; Mass Spectrometry; Sex Factors; Statistics, Nonparametric	2011
Association of N-acetylaspartate and cerebrospinal fluid Aβ42 in dementia. Journal of Alzheimer's disease : JAD, 2011, Volume: 27, Issue:2 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Dementia; Female; Humans; Male; Middle Aged; Mitochondria; Neurons; Peptide Fragments	2011
Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study. American journal of Alzheimer's disease and other dementias, 2011, Volume: 26, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Cross-Sectional Studies; Female; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Severity of Illness Index	2011
N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI). Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:12 Topics: Aged; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Temporal Lobe	2011
Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease. Dementia and geriatric cognitive disorders, 2011, Volume: 32, Issue:5 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Cognitive Dysfunction; Creatine; Diagnosis, Differential; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Mental Status Schedule; Neuropsychological Tests; Parietal Lobe; Predictive Value of Tests; Reference Values; Temporal Lobe	2011
Longitudinal magnetic resonance spectroscopy as marker of cognitive deterioration in mild cognitive impairment. American journal of Alzheimer's disease and other dementias, 2011, Volume: 26, Issue:8 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Cognitive Dysfunction; Creatine; Female; Follow-Up Studies; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged	2011
Functional investigation of bilateral posterior cingulate gyri using multivoxel MR spectroscopy. European neurology, 2012, Volume: 67, Issue:5 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Cognitive Dysfunction; Creatine; Female; Functional Laterality; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Republic of Korea; Retrospective Studies; Statistics as Topic	2012
Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease. Dementia and geriatric cognitive disorders, 2012, Volume: 34, Issue:5-6 Topics: Aged, 80 and over; Aspartic Acid; Brain Chemistry; Cognition; Cognitive Dysfunction; Data Interpretation, Statistical; Dementia; Disease Progression; Executive Function; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Temporal Lobe; Tomography, X-Ray Computed	2012
Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment. Parkinsonism & related disorders, 2013, Volume: 19, Issue:3 Topics: Aged; Aspartic Acid; Biomarkers; Brain; Brain Chemistry; Choline; Cognitive Dysfunction; Early Diagnosis; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease	2013